Thomas George

Thomas George, M.D., FACP, FASCO, was interviewed by AAMC News on how GLP-1 medications affect cancer risk and mortality.

Thomas George, M.D., FACP, FASCO, has been named interim director of the UF Health Cancer Institute.

He shares his expertise on takeaways and discusses UF research looking at a potential link between energy drinks and colorectal cancer risk.

At the UF Health Cancer Center, researchers and doctors are not just focused on today’s care. They’re looking to improve it for patients tomorrow.

The podcast discusses the NRG-GI008 study evaluating what chemotherapy to recommend based on circulating tumor DNA after colon cancer surgery.

Learn about the latest research on colorectal cancer and get resources.

On the anniversary of achieving NCI designation, a look at 10 key achievements over the past year.

Recipients are recognized for efforts that benefit ASCO, the speciality of oncology and the patients they serve.

The five-year award aims to encourage the development of stable research career opportunities for exceptional clinician scientists.

Thomas George, M.D., deputy director of the UF Health Cancer Center, discussed NCI designation at the breakfast on Sept. 13.